A Multicenter, Randomized, Double-Masked, Placebo-Controlled Pilot Study to Evaluate the Efficacy and Safety of ZOC2017217 in Subjects With Age-Related Cataract

NCT07395986 · clinicaltrials.gov ↗

PHASE2

Phase

ENROLLING_BY_INVITATION

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Age Related Cataracts

Interventions

DRUG: 0.4% ZOC2017217
DRUG: Control

Sponsor

Ocusun Ophthalmic Pharmaceutical (Guangzhou) Co., Ltd.